{"id":49144,"date":"2022-10-04T17:01:47","date_gmt":"2022-10-04T15:01:47","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/kintsugi-earns-frost-sullivans-best-practices-technology-innovation-leadership-award\/"},"modified":"2022-10-04T17:01:47","modified_gmt":"2022-10-04T15:01:47","slug":"kintsugi-earns-frost-sullivans-best-practices-technology-innovation-leadership-award","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/kintsugi-earns-frost-sullivans-best-practices-technology-innovation-leadership-award\/","title":{"rendered":"Kintsugi Earns Frost & Sullivan\u2019s Best Practices Technology Innovation Leadership Award"},"content":{"rendered":"
\n

BERKELEY, Calif.–(BUSINESS WIRE)–Kintsugi<\/a>, a startup developing voice biomarker technology to detect signs of depression and anxiety from short speech clips, has earned the 2022 Frost & Sullivan Technology Innovation Leadership Award: North American Vocal Biomarkers for Mental Health Industry – Excellence in Best Practices. The award recognizes companies at the forefront of innovation and growth in their respective industries.\n<\/p>\n

<\/a><\/p>\n

\nKintsugi\u2019s machine learning algorithms analyze short clips of free-form speech for vocal signs of clinical depression and anxiety. Their API platform Kintsugi Voice makes real-time assessments of patients\u2019 mental health, supporting primary care practitioners in deciding who needs further care.\n<\/p>\n

\nThe tool integrates seamlessly with clinical call centers, telehealth platforms, and remote patient monitoring apps, augmenting a practitioner\u2019s ability to evaluate patients\u2019 behavioral health objectively and accurately. Kintsugi Voice is language-agnostic since it focuses on universal speech features instead of the actual words being said. In addition, the machine learning model is developed using the largest dataset in the world for voice biomarkers and mental health, collected via Kintsugi\u2019s award-winning consumer wellness app in over 250 international cities and multiple languages.\n<\/p>\n

\nThe Berkeley startup was selected for its groundbreaking technology, which aims to bridge important access gaps in mental health care. According to Frost & Sullivan\u2019s analysis, Kintsugi Voice is the first and only voice biomarker technology developing a real-time mental health assessment using as little as 20 seconds of audio. The company continues to improve and further validate its technology by deploying it across different settings and patient circumstances via clinical partnerships with a number of hospitals and health organizations.\n<\/p>\n

\n\u201cIt is an honor to receive Frost & Sullivan\u2019s 2022 Best Practices Technology Innovation Leadership Award,\u201d said Grace Chang, Founder and CEO of Kintsugi. \u201cTraditionally, primary care mental health screening has been based on subjective analysis and self-reporting. At Kintsugi, we aim to empower practitioners with an objective and quantifiable mental health screening tool. Frost & Sullivan\u2019s analysis and due diligence in voice biomarkers for mental health is a significant milestone for innovation in healthcare.\u201d\n<\/p>\n

\nKintsugi recently announced a $20M Series A, bringing the company\u2019s total capital raised to $28M since its inception in 2019. The funding round was led by New York-based global venture capital and private equity firm Insight Partners and will help Kintsugi scale access to mental healthcare for more people in need. In addition, the company was one of the startups listed in Forbes\u2019 2022 AI 50 in North America.\n<\/p>\n

\nAbout Kintsugi:<\/b>\n<\/p>\n

\nKintsugi is developing novel voice biomarker software to detect signs of clinical depression and anxiety from short clips of free-form speech, closing mental health care gaps across risk-bearing health systems, saving time and lives. Based in Berkeley, California, Kintsugi is on a mission to provide equitable access to mental healthcare for all.\n<\/p>\n

\nAbout Frost & Sullivan:<\/b>\n<\/p>\n

\nFor six decades, Frost & Sullivan has been world-renowned for helping investors, corporate leaders, and governments navigate economic changes and identify disruptive technologies, Mega Trends, new business models, and companies to action, resulting in a continuous flow of growth opportunities to drive future success. Contact us: Start the discussion.<\/a>\n<\/p>\n

Contacts<\/b> <\/p>\n

\nLorraine@Kintsugihealth.com<\/a>, 484-358-5649\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

BERKELEY, Calif.–(BUSINESS WIRE)–Kintsugi, a startup developing voice biomarker technology to detect signs of depression and anxiety from short speech clips, has earned the 2022 Frost & Sullivan Technology Innovation Leadership Award: North American Vocal Biomarkers for Mental Health Industry – Excellence in Best Practices. The award recognizes companies at the forefront of innovation and growth … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-49144","6":"format-standard","7":"category-industry"},"yoast_head":"\nKintsugi Earns Frost & Sullivan\u2019s Best Practices Technology Innovation Leadership Award - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/kintsugi-earns-frost-sullivans-best-practices-technology-innovation-leadership-award\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Kintsugi Earns Frost & Sullivan\u2019s Best Practices Technology Innovation Leadership Award - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"BERKELEY, Calif.–(BUSINESS WIRE)–Kintsugi, a startup developing voice biomarker technology to detect signs of depression and anxiety from short speech clips, has earned the 2022 Frost & Sullivan Technology Innovation Leadership Award: North American Vocal Biomarkers for Mental Health Industry – Excellence in Best Practices. The award recognizes companies at the forefront of innovation and growth ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/kintsugi-earns-frost-sullivans-best-practices-technology-innovation-leadership-award\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-04T15:01:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221004005203\/en\/1590272\/21\/Kintsugi_LogoLockup_Black-RGB.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/kintsugi-earns-frost-sullivans-best-practices-technology-innovation-leadership-award\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/kintsugi-earns-frost-sullivans-best-practices-technology-innovation-leadership-award\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Kintsugi Earns Frost & Sullivan\u2019s Best Practices Technology Innovation Leadership Award\",\"datePublished\":\"2022-10-04T15:01:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/kintsugi-earns-frost-sullivans-best-practices-technology-innovation-leadership-award\\\/\"},\"wordCount\":532,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/kintsugi-earns-frost-sullivans-best-practices-technology-innovation-leadership-award\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221004005203\\\/en\\\/1590272\\\/21\\\/Kintsugi_LogoLockup_Black-RGB.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/kintsugi-earns-frost-sullivans-best-practices-technology-innovation-leadership-award\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/kintsugi-earns-frost-sullivans-best-practices-technology-innovation-leadership-award\\\/\",\"name\":\"Kintsugi Earns Frost & Sullivan\u2019s Best Practices Technology Innovation Leadership Award - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/kintsugi-earns-frost-sullivans-best-practices-technology-innovation-leadership-award\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/kintsugi-earns-frost-sullivans-best-practices-technology-innovation-leadership-award\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221004005203\\\/en\\\/1590272\\\/21\\\/Kintsugi_LogoLockup_Black-RGB.jpg\",\"datePublished\":\"2022-10-04T15:01:47+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/kintsugi-earns-frost-sullivans-best-practices-technology-innovation-leadership-award\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/kintsugi-earns-frost-sullivans-best-practices-technology-innovation-leadership-award\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/kintsugi-earns-frost-sullivans-best-practices-technology-innovation-leadership-award\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221004005203\\\/en\\\/1590272\\\/21\\\/Kintsugi_LogoLockup_Black-RGB.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221004005203\\\/en\\\/1590272\\\/21\\\/Kintsugi_LogoLockup_Black-RGB.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/kintsugi-earns-frost-sullivans-best-practices-technology-innovation-leadership-award\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Kintsugi Earns Frost & Sullivan\u2019s Best Practices Technology Innovation Leadership Award\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Kintsugi Earns Frost & Sullivan\u2019s Best Practices Technology Innovation Leadership Award - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/kintsugi-earns-frost-sullivans-best-practices-technology-innovation-leadership-award\/","og_locale":"en_US","og_type":"article","og_title":"Kintsugi Earns Frost & Sullivan\u2019s Best Practices Technology Innovation Leadership Award - Pharma Trend","og_description":"BERKELEY, Calif.–(BUSINESS WIRE)–Kintsugi, a startup developing voice biomarker technology to detect signs of depression and anxiety from short speech clips, has earned the 2022 Frost & Sullivan Technology Innovation Leadership Award: North American Vocal Biomarkers for Mental Health Industry – Excellence in Best Practices. The award recognizes companies at the forefront of innovation and growth ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/kintsugi-earns-frost-sullivans-best-practices-technology-innovation-leadership-award\/","og_site_name":"Pharma Trend","article_published_time":"2022-10-04T15:01:47+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221004005203\/en\/1590272\/21\/Kintsugi_LogoLockup_Black-RGB.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/kintsugi-earns-frost-sullivans-best-practices-technology-innovation-leadership-award\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/kintsugi-earns-frost-sullivans-best-practices-technology-innovation-leadership-award\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Kintsugi Earns Frost & Sullivan\u2019s Best Practices Technology Innovation Leadership Award","datePublished":"2022-10-04T15:01:47+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/kintsugi-earns-frost-sullivans-best-practices-technology-innovation-leadership-award\/"},"wordCount":532,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/kintsugi-earns-frost-sullivans-best-practices-technology-innovation-leadership-award\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221004005203\/en\/1590272\/21\/Kintsugi_LogoLockup_Black-RGB.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/kintsugi-earns-frost-sullivans-best-practices-technology-innovation-leadership-award\/","url":"https:\/\/pharma-trend.com\/en\/kintsugi-earns-frost-sullivans-best-practices-technology-innovation-leadership-award\/","name":"Kintsugi Earns Frost & Sullivan\u2019s Best Practices Technology Innovation Leadership Award - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/kintsugi-earns-frost-sullivans-best-practices-technology-innovation-leadership-award\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/kintsugi-earns-frost-sullivans-best-practices-technology-innovation-leadership-award\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221004005203\/en\/1590272\/21\/Kintsugi_LogoLockup_Black-RGB.jpg","datePublished":"2022-10-04T15:01:47+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/kintsugi-earns-frost-sullivans-best-practices-technology-innovation-leadership-award\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/kintsugi-earns-frost-sullivans-best-practices-technology-innovation-leadership-award\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/kintsugi-earns-frost-sullivans-best-practices-technology-innovation-leadership-award\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221004005203\/en\/1590272\/21\/Kintsugi_LogoLockup_Black-RGB.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221004005203\/en\/1590272\/21\/Kintsugi_LogoLockup_Black-RGB.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/kintsugi-earns-frost-sullivans-best-practices-technology-innovation-leadership-award\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Kintsugi Earns Frost & Sullivan\u2019s Best Practices Technology Innovation Leadership Award"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49144","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=49144"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49144\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=49144"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=49144"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=49144"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}